Retour

Globus Medical (GMED) Q1 2024 Earnings Call Transcript

News earningscall-transcripts

GMED earnings call for the period ending March 31, 2024.

The Motley Fool • 08/05/2024 à 06:45:20
GLOBUS MEDICAL INC
Address: 2560 GENERAL ARMISTEAD AVENUE
Postal Code: 19403
City: AUDUBON
State: PA
Phone Number: 610-930-1800
Website: https://www.globusmedical.com
Status: Active
Company Info

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include advanced computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States.

List Date2012-08-03
MarketStocks
LocalUS
Primary ExchangeXNYS
TypeCS
Currency NameUSD
CIK0001237831
Composite figiBBG002V87SD0
Share Class figiBBG002V87T57
Market Cap8,697,693,984 USD
SIC Code3841
SIC DescriptionSURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Total Employees5000
Share Class Shares Outstanding112630000
Weighted Shares Outstanding135057360
Round Lot100
Updated date2024-05-19
Stats
Last 5 days
17-05
16-05
15-05
14-05
13-05
Last
64.401
63.965
62.725
61.53
63.744
Variance
0.69%
1.55%
-0.18%
-3.26%
2.09%
Open
63.962
62.99
62.84
63.603
62.436
Highest
64.502
65.237
64.772
64.33
64.824
Lowest
64.461
65.177
64.739
64.329
64.806
History
PeriodVarhighestlowest
1 week
3.15%
64.824
64.329
1 month
27.89%
51.513
50.72
3 month
18.68%
57.45
48.386
6 month
41.57%
45.69
44.02
1 year
12.71%
57.61
43.385
3 year
-9.31%
71.04
43.385
5 year
52.43%
42.29
33.41
10 year
161.16%
24.91
17.45
Stock Financials
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Assets 2,149,620,000 2,212,465,000 5,355,875,000 UNPUB
Current Assets 1,070,429,000 1,210,010,000 1,917,337,000 UNPUB
Current Liabilities 167,547,000 155,220,000 428,722,000 UNPUB
Equity 1,914,820,000 1,985,065,000 4,187,285,000 UNPUB
Equity Attributable To Noncontrolling Interest 0 0 0 UNPUB
Equity Attributable To Parent 1,914,820,000 1,985,065,000 4,187,285,000 UNPUB
Liabilities 234,800,000 227,400,000 1,168,590,000 UNPUB
Liabilities And Equity 2,149,620,000 2,212,465,000 5,355,875,000 UNPUB
Noncurrent Assets 1,079,191,000 1,002,455,000 3,438,538,000 UNPUB
Noncurrent Liabilities 67,253,000 72,180,000 739,868,000 UNPUB
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Exchange Gains/Losses -26,000 433,000 2,120,000 UNPUB
Net Cash Flow 67,219,000 88,767,000 -26,832,000 UNPUB
Net Cash Flow, Continuing 67,245,000 88,334,000 -28,952,000 UNPUB
Net Cash Flow From Financing Activities 2,940,000 1,084,000 1,425,000 UNPUB
Net Cash Flow From Financing Activities, Continuing 2,940,000 1,084,000 1,425,000 UNPUB
Net Cash Flow From Investing Activities 10,992,000 52,222,000 -80,861,000 UNPUB
Net Cash Flow From Investing Activities, Continuing 10,992,000 52,222,000 -80,861,000 UNPUB
Net Cash Flow From Operating Activities 53,313,000 35,028,000 50,484,000 UNPUB
Net Cash Flow From Operating Activities, Continuing 53,313,000 35,028,000 50,484,000 UNPUB
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Comprehensive Income/Loss 54,337,000 58,067,000 1,329,000 UNPUB
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Comprehensive Income/Loss Attributable To Parent 54,337,000 58,067,000 1,329,000 UNPUB
Other Comprehensive Income/Loss 54,337,000 58,067,000 1,329,000 UNPUB
Other Comprehensive Income/Loss Attributable To Parent 5,208,000 355,000 331,000 UNPUB
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2023-05-04 2023-08-03 2023-11-07 UNPUB
Basic Earnings Per Share 0 1 0 UNPUB
Benefits Costs and Expenses 213,499,000 216,941,000 381,104,000 UNPUB
Cost Of Revenue 70,825,000 76,473,000 135,390,000 UNPUB
Costs And Expenses 213,499,000 216,941,000 381,104,000 UNPUB
Diluted Earnings Per Share 0 1 0 UNPUB
Gross Profit 205,863,000 215,142,000 248,249,000 UNPUB
Income/Loss From Continuing Operations After Tax 49,129,000 57,712,000 998,000 UNPUB
Income/Loss From Continuing Operations Before Tax 63,189,000 74,674,000 2,535,000 UNPUB
Income Tax Expense/Benefit 14,060,000 16,962,000 1,537,000 UNPUB
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 49,129,000 57,712,000 998,000 UNPUB
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 UNPUB
Net Income/Loss Attributable To Parent 49,129,000 57,712,000 998,000 UNPUB
Net Income/Loss Available To Common Stockholders, Basic 49,129,000 57,712,000 998,000 UNPUB
Operating Expenses 149,460,000 148,930,000 247,845,000 UNPUB
Operating Income/Loss 56,403,000 66,212,000 404,000 UNPUB
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 UNPUB
Preferred Stock Dividends And Other Adjustments 0 0 0 UNPUB
Revenues 276,688,000 291,615,000 383,639,000 UNPUB
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-08 2023-02-21
Assets 1,998,694,000 1,914,712,000 1,976,512,000 2,076,126,000
Current Assets 916,598,000 891,168,000 920,001,000 983,344,000
Current Liabilities 141,491,000 146,017,000 145,255,000 159,204,000
Equity 1,785,372,000 1,699,093,000 1,764,111,000 1,846,373,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,785,372,000 1,699,093,000 1,764,111,000 1,846,373,000
Liabilities 213,322,000 215,619,000 212,401,000 229,753,000
Liabilities And Equity 1,998,694,000 1,914,712,000 1,976,512,000 2,076,126,000
Noncurrent Assets 1,082,096,000 1,023,544,000 1,056,511,000 1,092,782,000
Noncurrent Liabilities 0 0 0 70,549,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-08 2023-02-21
Exchange Gains/Losses -123,000 -264,000 479,000 -747,000
Net Cash Flow 36,720,000 -79,017,000 -16,549,000 -42,603,000
Net Cash Flow, Continuing 36,843,000 -78,753,000 -17,028,000 -41,856,000
Net Cash Flow From Financing Activities 6,047,000 -142,762,000 13,162,000 -109,962,000
Net Cash Flow From Financing Activities, Continuing 6,047,000 -142,762,000 13,162,000 -109,962,000
Net Cash Flow From Investing Activities -13,894,000 27,126,000 -63,110,000 -110,362,000
Net Cash Flow From Investing Activities, Continuing -13,894,000 27,126,000 -63,110,000 -110,362,000
Net Cash Flow From Operating Activities 44,690,000 36,883,000 32,920,000 178,468,000
Net Cash Flow From Operating Activities, Continuing 44,690,000 36,883,000 32,920,000 178,468,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-08 2023-02-21
Comprehensive Income/Loss 27,689,000 46,389,000 40,573,000 172,311,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 27,689,000 46,389,000 40,573,000 172,311,000
Other Comprehensive Income/Loss 27,689,000 46,389,000 40,573,000 172,311,000
Other Comprehensive Income/Loss Attributable To Parent -10,395,000 -8,201,000 -6,858,000 -17,858,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2022-05-10 2022-08-04 2022-11-08 2023-02-21
Basic Earnings Per Share 0 1 0 2
Benefits Costs and Expenses 181,651,000 193,108,000 192,683,000 779,824,000
Cost Of Revenue 59,167,000 68,470,000 65,497,000 263,725,000
Costs And Expenses 181,651,000 193,108,000 192,683,000 779,824,000
Diluted Earnings Per Share 0 1 0 2
Gross Profit 171,382,000 195,178,000 188,651,000 759,118,000
Income/Loss From Continuing Operations After Tax 38,084,000 54,590,000 47,431,000 190,169,000
Income/Loss From Continuing Operations Before Tax 48,898,000 70,540,000 61,465,000 243,019,000
Income Tax Expense/Benefit 10,814,000 15,950,000 14,034,000 52,850,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 38,084,000 54,590,000 47,431,000 190,169,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 38,084,000 54,590,000 47,431,000 190,169,000
Net Income/Loss Available To Common Stockholders, Basic 38,084,000 54,590,000 47,431,000 190,169,000
Operating Expenses 124,937,000 127,402,000 128,949,000 531,167,000
Operating Income/Loss 46,445,000 67,776,000 59,702,000 227,951,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 230,549,000 263,648,000 254,148,000 1,022,843,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-04 2022-02-17
Assets 1,737,890,000 1,830,213,000 1,910,578,000 1,957,263,000
Current Assets 814,373,000 891,998,000 980,514,000 864,516,000
Current Liabilities 123,677,000 130,042,000 122,525,000 140,164,000
Equity 1,562,994,000 1,639,273,000 1,718,269,000 1,741,388,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,562,994,000 1,639,273,000 1,718,269,000 1,741,388,000
Liabilities 174,896,000 190,940,000 192,309,000 215,875,000
Liabilities And Equity 1,737,890,000 1,830,213,000 1,910,578,000 1,957,263,000
Noncurrent Assets 923,517,000 938,215,000 930,064,000 1,092,747,000
Noncurrent Liabilities 0 0 0 75,711,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-04 2022-02-17
Exchange Gains/Losses -569,000 -39,000 38,000 -810,000
Net Cash Flow -54,549,000 83,935,000 93,093,000 -46,328,000
Net Cash Flow, Continuing -53,980,000 83,974,000 93,055,000 -45,518,000
Net Cash Flow From Financing Activities 7,564,000 24,928,000 22,678,000 54,147,000
Net Cash Flow From Financing Activities, Continuing 7,564,000 24,928,000 22,678,000 54,147,000
Net Cash Flow From Investing Activities -125,114,000 -143,000 -6,885,000 -375,939,000
Net Cash Flow From Investing Activities, Continuing -125,114,000 -143,000 -6,885,000 -375,939,000
Net Cash Flow From Operating Activities 63,570,000 59,189,000 77,262,000 276,274,000
Net Cash Flow From Operating Activities, Continuing 63,570,000 59,189,000 77,262,000 276,274,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-04 2022-02-17
Comprehensive Income/Loss 39,550,000 41,797,000 45,729,000 138,464,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 39,550,000 41,797,000 45,729,000 138,464,000
Other Comprehensive Income/Loss 39,550,000 41,797,000 45,729,000 138,464,000
Other Comprehensive Income/Loss Attributable To Parent -5,779,000 252,000 -1,482,000 -10,727,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2021-05-04 2021-08-04 2021-11-04 2022-02-17
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 170,150,000 202,083,000 175,269,000 777,695,000
Cost Of Revenue 55,027,000 63,846,000 58,554,000 239,223,000
Costs And Expenses 170,150,000 202,083,000 175,269,000 777,695,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 172,317,000 187,170,000 171,167,000 718,879,000
Income/Loss From Continuing Operations After Tax 45,329,000 41,545,000 47,211,000 149,191,000
Income/Loss From Continuing Operations Before Tax 57,194,000 48,933,000 54,452,000 180,407,000
Income Tax Expense/Benefit 11,865,000 7,388,000 7,241,000 31,216,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 45,329,000 41,545,000 47,211,000 149,191,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 45,329,000 41,545,000 47,211,000 149,191,000
Net Income/Loss Available To Common Stockholders, Basic 45,329,000 41,545,000 47,211,000 149,191,000
Operating Expenses 117,769,000 141,294,000 117,838,000 546,926,000
Operating Income/Loss 54,548,000 45,876,000 53,329,000 171,953,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 227,344,000 251,016,000 229,721,000 958,102,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-05 2020-10-28 2021-02-17
Assets 1,479,365,000 1,465,802,000 1,541,739,000 1,679,485,000
Current Assets 641,800,000 696,891,000 811,951,000 821,765,000
Current Liabilities 97,962,000 106,126,000 99,980,000 120,792,000
Equity 1,363,366,000 1,336,915,000 1,417,204,000 1,506,297,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,363,366,000 1,336,915,000 1,417,204,000 1,506,297,000
Liabilities 115,999,000 128,887,000 124,535,000 173,188,000
Liabilities And Equity 1,479,365,000 1,465,802,000 1,541,739,000 1,679,485,000
Noncurrent Assets 837,565,000 768,911,000 729,788,000 857,720,000
Noncurrent Liabilities 0 0 0 52,396,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-05 2020-10-28 2021-02-17
Exchange Gains/Losses -16,000 -66,000 461,000 865,000
Net Cash Flow -28,982,000 -1,188,000 85,053,000 43,673,000
Net Cash Flow, Continuing -28,966,000 -1,122,000 84,592,000 42,808,000
Net Cash Flow From Financing Activities -68,667,000 -20,891,000 23,683,000 -38,663,000
Net Cash Flow From Financing Activities, Continuing -68,667,000 -20,891,000 23,683,000 -38,663,000
Net Cash Flow From Investing Activities -2,592,000 -3,299,000 7,661,000 -117,322,000
Net Cash Flow From Investing Activities, Continuing -2,592,000 -3,299,000 7,661,000 -117,322,000
Net Cash Flow From Operating Activities 42,293,000 23,068,000 53,248,000 198,793,000
Net Cash Flow From Operating Activities, Continuing 42,293,000 23,068,000 53,248,000 198,793,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-05 2020-10-28 2021-02-17
Comprehensive Income/Loss 22,581,000 -13,273,000 45,125,000 109,138,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 22,581,000 -13,273,000 45,125,000 109,138,000
Other Comprehensive Income/Loss 22,581,000 -13,273,000 45,125,000 109,138,000
Other Comprehensive Income/Loss Attributable To Parent -3,368,000 7,564,000 909,000 6,853,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2020-05-07 2020-08-05 2020-10-28 2021-02-17
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 663,143,000
Cost Of Revenue 48,864,000 50,643,000 57,097,000 217,463,000
Costs And Expenses 0 0 0 663,143,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 141,713,000 98,279,000 159,001,000 571,579,000
Income/Loss From Continuing Operations After Tax 25,949,000 -20,837,000 44,216,000 102,285,000
Income/Loss From Continuing Operations Before Tax 32,498,000 -21,942,000 53,130,000 125,899,000
Income Tax Expense/Benefit 6,549,000 -1,105,000 8,914,000 23,614,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 25,949,000 -20,837,000 44,216,000 102,285,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 25,949,000 -20,837,000 44,216,000 102,285,000
Net Income/Loss Available To Common Stockholders, Basic 25,949,000 -20,837,000 44,216,000 102,285,000
Operating Expenses 113,265,000 123,842,000 108,988,000 460,146,000
Operating Income/Loss 28,448,000 -25,563,000 50,013,000 111,433,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 190,577,000 148,922,000 216,098,000 789,042,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-11-06 2020-02-20
Assets 1,335,919,000 1,390,746,000 1,452,182,000 1,532,077,000
Current Assets 617,568,000 583,933,000 637,063,000 687,468,000
Current Liabilities 79,492,000 84,184,000 94,921,000 111,403,000
Equity 1,237,214,000 1,287,526,000 1,338,795,000 1,402,452,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,237,214,000 1,287,526,000 1,338,795,000 1,402,452,000
Liabilities 98,705,000 103,220,000 113,387,000 129,625,000
Liabilities And Equity 1,335,919,000 1,390,746,000 1,452,182,000 1,532,077,000
Noncurrent Assets 718,351,000 806,813,000 815,119,000 844,609,000
Noncurrent Liabilities 0 0 18,466,000 18,222,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-11-06 2020-02-20
Exchange Gains/Losses -40,000 226,000 -417,000 -156,000
Net Cash Flow -9,771,000 -12,186,000 48,400,000 55,977,000
Net Cash Flow, Continuing -9,731,000 -12,412,000 48,817,000 56,133,000
Net Cash Flow From Financing Activities 4,905,000 1,730,000 6,619,000 24,439,000
Net Cash Flow From Financing Activities, Continuing 4,905,000 1,730,000 6,619,000 24,439,000
Net Cash Flow From Investing Activities -53,839,000 -36,739,000 -13,668,000 -140,281,000
Net Cash Flow From Investing Activities, Continuing -53,839,000 -36,739,000 -13,668,000 -140,281,000
Net Cash Flow From Operating Activities 39,203,000 22,597,000 55,866,000 171,975,000
Net Cash Flow From Operating Activities, Continuing 39,203,000 22,597,000 55,866,000 171,975,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-11-06 2020-02-20
Comprehensive Income/Loss 33,210,000 38,163,000 38,307,000 159,484,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 34,902,000 41,915,000 37,209,000 159,484,000
Other Comprehensive Income/Loss 0 0 0 159,484,000
Other Comprehensive Income/Loss Attributable To Parent 1,692,000 3,752,000 -1,098,000 4,274,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2019-05-02 2019-08-01 2019-11-06 2020-02-20
Basic Earnings Per Share 0 0 0 2
Benefits Costs and Expenses 0 0 0 595,422,000
Cost Of Revenue 41,838,000 43,990,000 45,387,000 179,975,000
Costs And Expenses 0 0 0 595,422,000
Diluted Earnings Per Share 0 0 0 2
Gross Profit 141,109,000 150,549,000 150,828,000 605,393,000
Income/Loss From Continuing Operations After Tax 33,210,000 38,163,000 38,307,000 155,210,000
Income/Loss From Continuing Operations Before Tax 41,651,000 47,093,000 46,752,000 189,946,000
Income Tax Expense/Benefit 8,441,000 8,930,000 8,445,000 34,736,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 33,210,000 38,163,000 38,307,000 155,210,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 33,210,000 38,163,000 38,307,000 155,210,000
Net Income/Loss Available To Common Stockholders, Basic 33,210,000 38,163,000 38,307,000 155,210,000
Operating Expenses 104,030,000 107,680,000 108,767,000 433,404,000
Operating Income/Loss 37,079,000 42,869,000 42,061,000 171,989,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 182,947,000 194,539,000 196,215,000 785,368,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-03 2018-08-02 2018-11-08 2019-02-21
Assets 1,127,660,000 1,193,833,000 1,238,506,000 1,300,670,000
Current Assets 614,925,000 633,224,000 646,401,000 630,681,000
Current Liabilities 82,552,000 80,280,000 81,718,000 96,118,000
Equity 1,026,868,000 1,097,186,000 1,141,117,000 1,185,516,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 1,026,868,000 1,097,186,000 1,141,117,000 1,185,516,000
Liabilities 100,792,000 96,647,000 97,389,000 115,154,000
Liabilities And Equity 1,127,660,000 1,193,833,000 1,238,506,000 1,300,670,000
Noncurrent Assets 512,735,000 560,609,000 592,105,000 669,989,000
Noncurrent Liabilities 18,240,000 16,367,000 15,671,000 19,036,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-03 2018-08-02 2018-11-08 2019-02-21
Exchange Gains/Losses 971,000 -1,042,000 -125,000 -256,000
Net Cash Flow 1,019,000 108,000 25,351,000 20,930,000
Net Cash Flow, Continuing 48,000 1,150,000 25,476,000 21,186,000
Net Cash Flow From Financing Activities 3,867,000 23,314,000 2,551,000 32,570,000
Net Cash Flow From Financing Activities, Continuing 3,867,000 23,314,000 2,551,000 32,570,000
Net Cash Flow From Investing Activities -56,114,000 -55,433,000 -28,863,000 -193,027,000
Net Cash Flow From Investing Activities, Continuing -56,114,000 -55,433,000 -28,863,000 -193,027,000
Net Cash Flow From Operating Activities 52,295,000 33,269,000 51,788,000 181,643,000
Net Cash Flow From Operating Activities, Continuing 52,295,000 33,269,000 51,788,000 181,643,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-03 2018-08-02 2018-11-08 2019-02-21
Comprehensive Income/Loss 39,538,000 44,977,000 35,208,000 156,209,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 43,673,000 40,936,000 35,188,000 156,209,000
Other Comprehensive Income/Loss 0 0 0 156,209,000
Other Comprehensive Income/Loss Attributable To Parent 4,135,000 -4,041,000 -20,000 -265,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2018-05-03 2018-08-02 2018-11-08 2019-02-21
Basic Earnings Per Share 0 0 0 2
Benefits Costs and Expenses 0 0 0 524,364,000
Cost Of Revenue 37,970,000 37,637,000 37,849,000 159,410,000
Costs And Expenses 0 0 0 524,364,000
Diluted Earnings Per Share 0 0 0 2
Gross Profit 136,441,000 135,747,000 131,387,000 553,559,000
Income/Loss From Continuing Operations After Tax 39,538,000 44,977,000 35,208,000 156,474,000
Income/Loss From Continuing Operations Before Tax 48,077,000 50,304,000 42,597,000 188,605,000
Income Tax Expense/Benefit 8,539,000 5,327,000 7,389,000 32,131,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 39,538,000 44,977,000 35,208,000 156,474,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 39,538,000 44,977,000 35,208,000 156,474,000
Net Income/Loss Available To Common Stockholders, Basic 39,538,000 44,977,000 35,208,000 156,474,000
Operating Expenses 90,808,000 93,608,000 93,086,000 384,234,000
Operating Income/Loss 45,633,000 42,139,000 38,301,000 169,325,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 174,411,000 173,384,000 169,236,000 712,969,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-04 2017-08-03 2017-11-09 2018-02-22
Assets 960,421,000 995,014,000 1,037,160,000 1,078,502,000
Current Assets 540,899,000 535,129,000 563,562,000 620,342,000
Current Liabilities 75,369,000 69,061,000 74,927,000 93,073,000
Equity 868,885,000 905,300,000 935,264,000 967,778,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 868,885,000 905,300,000 935,264,000 967,778,000
Liabilities 91,536,000 89,714,000 101,896,000 110,724,000
Liabilities And Equity 960,421,000 995,014,000 1,037,160,000 1,078,502,000
Noncurrent Assets 419,522,000 459,885,000 473,598,000 458,160,000
Noncurrent Liabilities 16,167,000 20,653,000 26,969,000 17,651,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-04 2017-08-03 2017-11-09 2018-02-22
Exchange Gains/Losses 321,000 129,000 328,000 1,979,000
Net Cash Flow 49,796,000 -32,766,000 5,186,000 51,863,000
Net Cash Flow, Continuing 49,475,000 -32,895,000 4,858,000 49,884,000
Net Cash Flow From Financing Activities -3,011,000 3,688,000 1,032,000 1,626,000
Net Cash Flow From Financing Activities, Continuing -3,011,000 3,688,000 1,032,000 1,626,000
Net Cash Flow From Investing Activities -963,000 -62,559,000 -31,447,000 -111,277,000
Net Cash Flow From Investing Activities, Continuing -963,000 -62,559,000 -31,447,000 -111,277,000
Net Cash Flow From Operating Activities 53,449,000 25,976,000 35,273,000 159,535,000
Net Cash Flow From Operating Activities, Continuing 53,449,000 25,976,000 35,273,000 159,535,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-04 2017-08-03 2017-11-09 2018-02-22
Comprehensive Income/Loss 28,714,000 28,667,000 25,591,000 109,083,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 31,275,000 28,876,000 25,285,000 109,083,000
Other Comprehensive Income/Loss 0 0 0 109,083,000
Other Comprehensive Income/Loss Attributable To Parent 2,561,000 209,000 -306,000 1,735,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2017-05-04 2017-08-03 2017-11-09 2018-02-22
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 466,049,000
Cost Of Revenue 35,600,000 37,199,000 36,798,000 150,453,000
Costs And Expenses 0 0 0 466,049,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 120,209,000 115,191,000 114,946,000 485,524,000
Income/Loss From Continuing Operations After Tax 28,714,000 28,667,000 25,591,000 107,348,000
Income/Loss From Continuing Operations Before Tax 42,414,000 39,557,000 37,357,000 169,928,000
Income Tax Expense/Benefit 13,700,000 10,890,000 11,766,000 62,580,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 28,714,000 28,667,000 25,591,000 107,348,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 28,714,000 28,667,000 25,591,000 107,348,000
Net Income/Loss Available To Common Stockholders, Basic 28,714,000 28,667,000 25,591,000 107,348,000
Operating Expenses 79,895,000 77,820,000 79,151,000 323,684,000
Operating Income/Loss 40,314,000 37,371,000 35,795,000 161,840,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 155,809,000 152,390,000 151,744,000 635,977,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-04 2016-07-27 2016-11-09 2017-03-16
Assets 839,988,000 869,476,000 901,743,000 927,637,000
Current Assets 515,498,000 535,429,000 478,210,000 513,766,000
Current Liabilities 72,337,000 70,280,000 65,807,000 79,892,000
Equity 748,885,000 779,531,000 810,119,000 832,078,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 748,885,000 779,531,000 810,119,000 832,078,000
Liabilities 91,103,000 89,945,000 91,624,000 95,559,000
Liabilities And Equity 839,988,000 869,476,000 901,743,000 927,637,000
Noncurrent Assets 324,490,000 334,047,000 423,533,000 413,871,000
Noncurrent Liabilities 18,766,000 19,665,000 25,817,000 15,667,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-04 2016-07-27 2016-11-09 2017-03-16
Exchange Gains/Losses 91,000 28,000 -2,443,000 -1,894,000
Net Cash Flow 21,123,000 14,067,000 -5,150,000 72,487,000
Net Cash Flow, Continuing 21,032,000 14,039,000 -2,707,000 74,381,000
Net Cash Flow From Financing Activities 2,105,000 1,834,000 1,573,000 2,041,000
Net Cash Flow From Financing Activities, Continuing 2,105,000 1,834,000 1,573,000 2,041,000
Net Cash Flow From Investing Activities -36,120,000 -10,811,000 -46,214,000 -99,553,000
Net Cash Flow From Investing Activities, Continuing -36,120,000 -10,811,000 -46,214,000 -99,553,000
Net Cash Flow From Operating Activities 55,047,000 23,016,000 41,934,000 171,893,000
Net Cash Flow From Operating Activities, Continuing 55,047,000 23,016,000 41,934,000 171,893,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-04 2016-07-27 2016-11-09 2017-03-16
Comprehensive Income/Loss 28,010,000 25,806,000 26,227,000 97,657,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 28,315,000 25,723,000 26,203,000 97,657,000
Other Comprehensive Income/Loss 0 0 0 97,657,000
Other Comprehensive Income/Loss Attributable To Parent 305,000 -83,000 -24,000 -6,684,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2016-05-04 2016-07-27 2016-11-09 2017-03-16
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 406,715,000
Cost Of Revenue 31,644,000 32,856,000 31,453,000 134,705,000
Costs And Expenses 0 0 0 406,715,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 107,745,000 104,758,000 104,198,000 429,289,000
Income/Loss From Continuing Operations After Tax 28,010,000 25,806,000 26,227,000 104,341,000
Income/Loss From Continuing Operations Before Tax 43,611,000 38,336,000 38,855,000 157,279,000
Income Tax Expense/Benefit 15,601,000 12,530,000 12,628,000 52,938,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 28,010,000 25,806,000 26,227,000 104,341,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 28,010,000 25,806,000 26,227,000 104,341,000
Net Income/Loss Available To Common Stockholders, Basic 28,010,000 25,806,000 26,227,000 104,341,000
Operating Expenses 64,769,000 66,715,000 66,548,000 275,148,000
Operating Income/Loss 42,851,000 37,918,000 37,650,000 154,141,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 139,264,000 137,489,000 135,651,000 563,994,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-05 2015-07-31 2015-11-04 2016-02-29
Assets 744,129,000 764,663,000 800,661,000 834,100,000
Current Assets 455,695,000 454,756,000 506,308,000 544,799,000
Current Liabilities 93,311,000 91,733,000 94,419,000 82,691,000
Equity 614,164,000 643,125,000 673,917,000 715,324,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 614,164,000 643,125,000 673,917,000 715,324,000
Liabilities 129,965,000 121,538,000 126,744,000 118,776,000
Liabilities And Equity 744,129,000 764,663,000 800,661,000 834,100,000
Noncurrent Assets 288,434,000 309,907,000 294,353,000 289,301,000
Noncurrent Liabilities 36,654,000 29,805,000 32,325,000 36,085,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-05 2015-07-31 2015-11-04 2016-02-29
Exchange Gains/Losses 41,000 -6,000 82,000 153,000
Net Cash Flow -7,259,000 -33,447,000 8,942,000 -22,113,000
Net Cash Flow, Continuing -7,300,000 -33,441,000 8,860,000 -22,266,000
Net Cash Flow From Financing Activities 1,809,000 1,923,000 1,654,000 6,327,000
Net Cash Flow From Financing Activities, Continuing 1,809,000 1,923,000 1,654,000 6,327,000
Net Cash Flow From Investing Activities -43,779,000 -48,525,000 -22,840,000 -150,550,000
Net Cash Flow From Investing Activities, Continuing -43,779,000 -48,525,000 -22,840,000 -150,550,000
Net Cash Flow From Operating Activities 34,670,000 13,161,000 30,046,000 121,957,000
Net Cash Flow From Operating Activities, Continuing 34,670,000 13,161,000 30,046,000 121,957,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-05 2015-07-31 2015-11-04 2016-02-29
Comprehensive Income/Loss 24,648,000 24,054,000 26,481,000 112,483,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 24,470,000 24,200,000 26,432,000 112,483,000
Other Comprehensive Income/Loss 0 0 0 112,483,000
Other Comprehensive Income/Loss Attributable To Parent -178,000 146,000 -49,000 -301,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2015-05-05 2015-07-31 2015-11-04 2016-02-29
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 371,948,000
Cost Of Revenue 32,107,000 32,579,000 33,052,000 132,803,000
Costs And Expenses 0 0 0 371,948,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 99,497,000 100,991,000 103,940,000 411,950,000
Income/Loss From Continuing Operations After Tax 24,648,000 24,054,000 26,481,000 112,784,000
Income/Loss From Continuing Operations Before Tax 38,173,000 37,471,000 40,928,000 172,805,000
Income Tax Expense/Benefit 13,525,000 13,417,000 14,447,000 60,021,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 24,648,000 24,054,000 26,481,000 112,784,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 24,648,000 24,054,000 26,481,000 112,784,000
Net Income/Loss Available To Common Stockholders, Basic 24,648,000 24,054,000 26,481,000 112,784,000
Operating Expenses 60,977,000 63,961,000 63,265,000 239,728,000
Operating Income/Loss 38,520,000 37,030,000 40,675,000 172,222,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 131,604,000 133,570,000 136,992,000 544,753,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-04-30 2014-08-06 2014-10-31 2015-02-26
Assets 599,422,000 618,000,000 646,439,000 703,547,000
Current Assets 460,901,000 467,100,000 484,813,000 470,025,000
Current Liabilities 72,491,000 65,970,000 72,759,000 89,412,000
Equity 502,065,000 528,310,000 553,808,000 585,454,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 502,065,000 528,310,000 553,808,000 585,454,000
Liabilities 97,357,000 89,690,000 92,631,000 118,093,000
Liabilities And Equity 599,422,000 618,000,000 646,439,000 703,547,000
Noncurrent Assets 138,521,000 150,900,000 161,626,000 233,522,000
Noncurrent Liabilities 24,866,000 23,720,000 19,872,000 28,681,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-04-30 2014-08-06 2014-10-31 2015-02-26
Exchange Gains/Losses -56,000 -61,000 162,000 185,000
Net Cash Flow 14,640,000 31,898,000 32,949,000 -7,697,000
Net Cash Flow, Continuing 14,696,000 31,959,000 32,787,000 -7,882,000
Net Cash Flow From Financing Activities 6,441,000 3,431,000 916,000 12,946,000
Net Cash Flow From Financing Activities, Continuing 6,441,000 3,431,000 916,000 12,946,000
Net Cash Flow From Investing Activities -20,977,000 16,178,000 -3,774,000 -100,000,000
Net Cash Flow From Investing Activities, Continuing -20,977,000 16,178,000 -3,774,000 -100,000,000
Net Cash Flow From Operating Activities 29,232,000 12,350,000 35,645,000 79,172,000
Net Cash Flow From Operating Activities, Continuing 29,232,000 12,350,000 35,645,000 79,172,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-04-30 2014-08-06 2014-10-31 2015-02-26
Comprehensive Income/Loss 21,139,000 20,647,000 23,061,000 91,837,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 21,137,000 20,791,000 22,621,000 91,837,000
Other Comprehensive Income/Loss 0 0 0 91,837,000
Other Comprehensive Income/Loss Attributable To Parent -2,000 144,000 -440,000 -648,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2014-04-30 2014-08-06 2014-10-31 2015-02-26
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 335,729,000
Cost Of Revenue 25,312,000 26,583,000 27,686,000 110,857,000
Costs And Expenses 0 0 0 335,729,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 88,898,000 86,990,000 90,101,000 363,514,000
Income/Loss From Continuing Operations After Tax 21,139,000 20,647,000 23,061,000 92,485,000
Income/Loss From Continuing Operations Before Tax 32,487,000 31,878,000 34,799,000 138,642,000
Income Tax Expense/Benefit 11,348,000 11,231,000 11,738,000 46,157,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 21,139,000 20,647,000 23,061,000 92,485,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 21,139,000 20,647,000 23,061,000 92,485,000
Net Income/Loss Available To Common Stockholders, Basic 21,139,000 20,647,000 23,061,000 92,485,000
Operating Expenses 56,656,000 55,437,000 55,178,000 225,152,000
Operating Income/Loss 32,242,000 31,553,000 34,923,000 138,362,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 114,210,000 113,573,000 117,787,000 474,371,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-02 2013-10-31 2014-03-14
Assets 473,620,000 498,075,000 524,672,000 566,304,000
Current Assets 323,435,000 337,882,000 384,764,000 416,808,000
Current Liabilities 45,274,000 56,635,000 58,480,000 67,942,000
Equity 408,300,000 422,133,000 448,376,000 472,360,000
Equity Attributable To Noncontrolling Interest 0 0 0 0
Equity Attributable To Parent 408,300,000 422,133,000 448,376,000 472,360,000
Liabilities 65,320,000 75,942,000 76,296,000 93,944,000
Liabilities And Equity 473,620,000 498,075,000 524,672,000 566,304,000
Noncurrent Assets 150,185,000 160,193,000 139,908,000 149,496,000
Noncurrent Liabilities 20,046,000 19,307,000 17,816,000 26,002,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-02 2013-10-31 2014-03-14
Exchange Gains/Losses 38,000 -3,000 163,000 230,000
Net Cash Flow -80,857,000 -39,229,000 9,593,000 -122,438,000
Net Cash Flow, Continuing -80,895,000 -39,226,000 9,430,000 -122,668,000
Net Cash Flow From Financing Activities 788,000 4,953,000 3,999,000 11,011,000
Net Cash Flow From Financing Activities, Continuing 788,000 4,953,000 3,999,000 11,011,000
Net Cash Flow From Investing Activities -99,959,000 -53,159,000 -28,126,000 -227,150,000
Net Cash Flow From Investing Activities, Continuing -99,959,000 -53,159,000 -28,126,000 -227,150,000
Net Cash Flow From Operating Activities 18,276,000 8,980,000 33,557,000 93,471,000
Net Cash Flow From Operating Activities, Continuing 18,276,000 8,980,000 33,557,000 93,471,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-02 2013-10-31 2014-03-14
Comprehensive Income/Loss 19,891,000 7,426,000 20,310,000 68,370,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Comprehensive Income/Loss Attributable To Parent 19,298,000 7,414,000 20,557,000 68,370,000
Other Comprehensive Income/Loss 0 0 0 68,370,000
Other Comprehensive Income/Loss Attributable To Parent -593,000 -12,000 247,000 -242,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date 2013-05-03 2013-08-02 2013-10-31 2014-03-14
Basic Earnings Per Share 0 0 0 1
Benefits Costs and Expenses 0 0 0 332,458,000
Cost Of Revenue 23,493,000 23,501,000 25,315,000 100,343,000
Costs And Expenses 0 0 0 332,458,000
Diluted Earnings Per Share 0 0 0 1
Gross Profit 81,525,000 82,248,000 81,872,000 334,116,000
Income/Loss From Continuing Operations After Tax 19,891,000 7,426,000 20,310,000 68,612,000
Income/Loss From Continuing Operations Before Tax 29,510,000 10,971,000 29,700,000 102,001,000
Income Tax Expense/Benefit 9,619,000 3,545,000 9,390,000 33,389,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss 19,891,000 7,426,000 20,310,000 68,612,000
Net Income/Loss Attributable To Noncontrolling Interest 0 0 0 0
Net Income/Loss Attributable To Parent 19,891,000 7,426,000 20,310,000 68,612,000
Net Income/Loss Available To Common Stockholders, Basic 19,891,000 7,426,000 20,310,000 68,612,000
Operating Expenses 52,294,000 71,056,000 52,369,000 232,443,000
Operating Income/Loss 29,231,000 11,192,000 29,503,000 101,673,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic 0 0 0 0
Preferred Stock Dividends And Other Adjustments 0 0 0 0
Revenues 105,018,000 107,009,000 107,187,000 434,459,000
Balance Sheet
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-05
Assets UNPUB UNPUB UNPUB 447,133,000
Current Assets UNPUB UNPUB UNPUB 360,110,000
Current Liabilities UNPUB UNPUB UNPUB 39,508,000
Equity UNPUB UNPUB UNPUB 386,502,000
Equity Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Equity Attributable To Parent UNPUB UNPUB UNPUB 386,502,000
Liabilities UNPUB UNPUB UNPUB 60,631,000
Liabilities And Equity UNPUB UNPUB UNPUB 447,133,000
Noncurrent Assets UNPUB UNPUB UNPUB 87,023,000
Noncurrent Liabilities UNPUB UNPUB UNPUB 21,123,000
Cash Flow Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-05
Exchange Gains/Losses UNPUB UNPUB UNPUB -97,000
Net Cash Flow UNPUB UNPUB UNPUB 69,732,000
Net Cash Flow, Continuing UNPUB UNPUB UNPUB 69,829,000
Net Cash Flow From Financing Activities UNPUB UNPUB UNPUB 24,025,000
Net Cash Flow From Financing Activities, Continuing UNPUB UNPUB UNPUB 24,025,000
Net Cash Flow From Investing Activities UNPUB UNPUB UNPUB -30,715,000
Net Cash Flow From Investing Activities, Continuing UNPUB UNPUB UNPUB -30,715,000
Net Cash Flow From Operating Activities UNPUB UNPUB UNPUB 76,519,000
Net Cash Flow From Operating Activities, Continuing UNPUB UNPUB UNPUB 76,519,000
Comprehensive Income
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-05
Comprehensive Income/Loss UNPUB UNPUB UNPUB 74,266,000
Comprehensive Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 74,266,000
Other Comprehensive Income/Loss UNPUB UNPUB UNPUB 74,266,000
Other Comprehensive Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 435,000
Income Statement
LabelQuarter 1 (USD)Quarter 2 (USD)Quarter 3 (USD)Full Year (USD)
Filing date UNPUB UNPUB UNPUB 2013-03-05
Basic Earnings Per Share UNPUB UNPUB UNPUB 1
Benefits Costs and Expenses UNPUB UNPUB UNPUB 271,341,000
Cost Of Revenue UNPUB UNPUB UNPUB 75,199,000
Costs And Expenses UNPUB UNPUB UNPUB 271,341,000
Diluted Earnings Per Share UNPUB UNPUB UNPUB 1
Gross Profit UNPUB UNPUB UNPUB 310,795,000
Income/Loss From Continuing Operations After Tax UNPUB UNPUB UNPUB 73,831,000
Income/Loss From Continuing Operations Before Tax UNPUB UNPUB UNPUB 114,653,000
Income Tax Expense/Benefit UNPUB UNPUB UNPUB 40,822,000
Interest Expense, Operating UNPUB UNPUB UNPUB UNPUB
Net Income/Loss UNPUB UNPUB UNPUB 73,831,000
Net Income/Loss Attributable To Noncontrolling Interest UNPUB UNPUB UNPUB 0
Net Income/Loss Attributable To Parent UNPUB UNPUB UNPUB 73,831,000
Net Income/Loss Available To Common Stockholders, Basic UNPUB UNPUB UNPUB 73,831,000
Operating Expenses UNPUB UNPUB UNPUB 196,002,000
Operating Income/Loss UNPUB UNPUB UNPUB 114,793,000
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic UNPUB UNPUB UNPUB 0
Preferred Stock Dividends And Other Adjustments UNPUB UNPUB UNPUB 0
Revenues UNPUB UNPUB UNPUB 385,994,000
Calendar
19 May 2024 (Time UTC) Actual Previous Consensus
★★★
15:30
United States
17 May 2024 (Time UTC) Actual Previous Consensus
★
15:30
United States
-17800.000
★
15:30
United States
-60000.000
★
15:30
United States
53700.000
★
15:30
United States
-135800.000
★★
15:30
United States
4400.000
★
15:30
United States
215400.000
★
15:30
United States
-31400.000
★
15:30
United States
62600.000
★
15:30
United States
1300.000
★
15:30
United States
-9700.000
★
15:30
United States
199600.000
★★
15:30
United States
★
15:30
United States
★
15:30
United States
Options
Ticker
CFI
Contract Type
Exercise Style
Share Per Contract
Strike Price
Primary Exchange
Expiration Date
O:GMED240517P00080000 OPASPS Put American 100 80 BATO 2024-05-17
O:GMED240517P00075000 OPASPS Put American 100 75 BATO 2024-05-17
O:GMED240517P00070000 OPASPS Put American 100 70 BATO 2024-05-17
O:GMED240517P00065000 OPASPS Put American 100 65 BATO 2024-05-17
O:GMED240517P00062500 OPASPS Put American 100 62.5 BATO 2024-05-17
O:GMED240517P00060000 OPASPS Put American 100 60 BATO 2024-05-17
O:GMED240517P00057500 OPASPS Put American 100 57.5 BATO 2024-05-17
O:GMED240517P00055000 OPASPS Put American 100 55 BATO 2024-05-17
O:GMED240517P00052500 OPASPS Put American 100 52.5 BATO 2024-05-17
O:GMED240517P00050000 OPASPS Put American 100 50 BATO 2024-05-17
O:GMED240517P00047500 OPASPS Put American 100 47.5 BATO 2024-05-17
O:GMED240517P00045000 OPASPS Put American 100 45 BATO 2024-05-17
O:GMED240517P00042500 OPASPS Put American 100 42.5 BATO 2024-05-17
O:GMED240517P00040000 OPASPS Put American 100 40 BATO 2024-05-17
O:GMED240517P00037500 OPASPS Put American 100 37.5 BATO 2024-05-17
O:GMED240517P00035000 OPASPS Put American 100 35 BATO 2024-05-17
O:GMED240517P00032500 OPASPS Put American 100 32.5 BATO 2024-05-17
O:GMED240517P00030000 OPASPS Put American 100 30 BATO 2024-05-17
O:GMED240517P00027500 OPASPS Put American 100 27.5 BATO 2024-05-17
O:GMED240517C00080000 OCASPS Call American 100 80 BATO 2024-05-17
O:GMED240517C00075000 OCASPS Call American 100 75 BATO 2024-05-17
O:GMED240517C00070000 OCASPS Call American 100 70 BATO 2024-05-17
O:GMED240517C00065000 OCASPS Call American 100 65 BATO 2024-05-17
O:GMED240517C00062500 OCASPS Call American 100 62.5 BATO 2024-05-17
O:GMED240517C00060000 OCASPS Call American 100 60 BATO 2024-05-17
O:GMED240517C00057500 OCASPS Call American 100 57.5 BATO 2024-05-17
O:GMED240517C00055000 OCASPS Call American 100 55 BATO 2024-05-17
O:GMED240517C00052500 OCASPS Call American 100 52.5 BATO 2024-05-17
O:GMED240517C00050000 OCASPS Call American 100 50 BATO 2024-05-17
O:GMED240517C00047500 OCASPS Call American 100 47.5 BATO 2024-05-17
O:GMED240517C00045000 OCASPS Call American 100 45 BATO 2024-05-17
O:GMED240517C00042500 OCASPS Call American 100 42.5 BATO 2024-05-17
O:GMED240517C00040000 OCASPS Call American 100 40 BATO 2024-05-17
O:GMED240517C00037500 OCASPS Call American 100 37.5 BATO 2024-05-17
O:GMED240517C00035000 OCASPS Call American 100 35 BATO 2024-05-17
O:GMED240517C00032500 OCASPS Call American 100 32.5 BATO 2024-05-17
O:GMED240517C00030000 OCASPS Call American 100 30 BATO 2024-05-17
O:GMED240517C00027500 OCASPS Call American 100 27.5 BATO 2024-05-17
O:GMED240517P00067500 OPASPS Put American 100 67.5 BATO 2024-05-17
O:GMED240517C00067500 OCASPS Call American 100 67.5 BATO 2024-05-17
O:GMED240419P00075000 OPASPS Put American 100 75 BATO 2024-04-19
O:GMED240419P00070000 OPASPS Put American 100 70 BATO 2024-04-19
O:GMED240419P00065000 OPASPS Put American 100 65 BATO 2024-04-19
O:GMED240419P00060000 OPASPS Put American 100 60 BATO 2024-04-19
O:GMED240419P00057500 OPASPS Put American 100 57.5 BATO 2024-04-19
O:GMED240419P00055000 OPASPS Put American 100 55 BATO 2024-04-19
O:GMED240419P00052500 OPASPS Put American 100 52.5 BATO 2024-04-19
O:GMED240419P00050000 OPASPS Put American 100 50 BATO 2024-04-19
O:GMED240419P00047500 OPASPS Put American 100 47.5 BATO 2024-04-19
O:GMED240419P00045000 OPASPS Put American 100 45 BATO 2024-04-19
O:GMED240419P00042500 OPASPS Put American 100 42.5 BATO 2024-04-19
O:GMED240419P00040000 OPASPS Put American 100 40 BATO 2024-04-19
O:GMED240419P00037500 OPASPS Put American 100 37.5 BATO 2024-04-19
O:GMED240419P00035000 OPASPS Put American 100 35 BATO 2024-04-19
O:GMED240419P00032500 OPASPS Put American 100 32.5 BATO 2024-04-19
O:GMED240419P00030000 OPASPS Put American 100 30 BATO 2024-04-19
O:GMED240419C00075000 OCASPS Call American 100 75 BATO 2024-04-19
O:GMED240419C00070000 OCASPS Call American 100 70 BATO 2024-04-19
O:GMED240419C00065000 OCASPS Call American 100 65 BATO 2024-04-19
O:GMED240419C00060000 OCASPS Call American 100 60 BATO 2024-04-19
O:GMED240419C00057500 OCASPS Call American 100 57.5 BATO 2024-04-19
O:GMED240419C00055000 OCASPS Call American 100 55 BATO 2024-04-19
O:GMED240419C00052500 OCASPS Call American 100 52.5 BATO 2024-04-19
O:GMED240419P00080000 OPASPS Put American 100 80 BATO 2024-04-19
O:GMED240419C00050000 OCASPS Call American 100 50 BATO 2024-04-19
O:GMED240419P00062500 OPASPS Put American 100 62.5 BATO 2024-04-19
O:GMED240419P00027500 OPASPS Put American 100 27.5 BATO 2024-04-19
O:GMED240419C00047500 OCASPS Call American 100 47.5 BATO 2024-04-19
O:GMED240419C00080000 OCASPS Call American 100 80 BATO 2024-04-19
O:GMED240419C00062500 OCASPS Call American 100 62.5 BATO 2024-04-19
O:GMED240419C00027500 OCASPS Call American 100 27.5 BATO 2024-04-19
O:GMED240419C00045000 OCASPS Call American 100 45 BATO 2024-04-19
O:GMED240419C00042500 OCASPS Call American 100 42.5 BATO 2024-04-19
O:GMED240419C00040000 OCASPS Call American 100 40 BATO 2024-04-19
O:GMED240419C00037500 OCASPS Call American 100 37.5 BATO 2024-04-19
O:GMED240419C00035000 OCASPS Call American 100 35 BATO 2024-04-19
O:GMED240419C00032500 OCASPS Call American 100 32.5 BATO 2024-04-19
O:GMED240419C00030000 OCASPS Call American 100 30 BATO 2024-04-19
O:GMED240315C00032500 OCASPS Call American 100 32.5 BATO 2024-03-15
O:GMED240315C00030000 OCASPS Call American 100 30 BATO 2024-03-15
O:GMED240315C00027500 OCASPS Call American 100 27.5 BATO 2024-03-15
O:GMED240315P00022500 OPASPS Put American 100 22.5 BATO 2024-03-15
O:GMED240315C00025000 OCASPS Call American 100 25 BATO 2024-03-15
O:GMED240315C00022500 OCASPS Call American 100 22.5 BATO 2024-03-15
O:GMED240315P00090000 OPASPS Put American 100 90 BATO 2024-03-15
O:GMED240315P00085000 OPASPS Put American 100 85 BATO 2024-03-15
O:GMED240315P00080000 OPASPS Put American 100 80 BATO 2024-03-15
O:GMED240315P00075000 OPASPS Put American 100 75 BATO 2024-03-15
O:GMED240315P00070000 OPASPS Put American 100 70 BATO 2024-03-15
O:GMED240315P00067500 OPASPS Put American 100 67.5 BATO 2024-03-15
O:GMED240315P00065000 OPASPS Put American 100 65 BATO 2024-03-15
O:GMED240315P00062500 OPASPS Put American 100 62.5 BATO 2024-03-15
O:GMED240315P00060000 OPASPS Put American 100 60 BATO 2024-03-15
O:GMED240315P00057500 OPASPS Put American 100 57.5 BATO 2024-03-15
O:GMED240315P00055000 OPASPS Put American 100 55 BATO 2024-03-15
O:GMED240315P00052500 OPASPS Put American 100 52.5 BATO 2024-03-15
O:GMED240315P00050000 OPASPS Put American 100 50 BATO 2024-03-15
O:GMED240315P00047500 OPASPS Put American 100 47.5 BATO 2024-03-15
O:GMED240315P00045000 OPASPS Put American 100 45 BATO 2024-03-15
O:GMED240315P00042500 OPASPS Put American 100 42.5 BATO 2024-03-15
O:GMED240315P00040000 OPASPS Put American 100 40 BATO 2024-03-15
O:GMED240315P00037500 OPASPS Put American 100 37.5 BATO 2024-03-15
O:GMED240315P00035000 OPASPS Put American 100 35 BATO 2024-03-15
O:GMED240315C00090000 OCASPS Call American 100 90 BATO 2024-03-15
O:GMED240315C00085000 OCASPS Call American 100 85 BATO 2024-03-15
O:GMED240315C00080000 OCASPS Call American 100 80 BATO 2024-03-15
O:GMED240315C00075000 OCASPS Call American 100 75 BATO 2024-03-15
O:GMED240315C00070000 OCASPS Call American 100 70 BATO 2024-03-15
O:GMED240315C00067500 OCASPS Call American 100 67.5 BATO 2024-03-15
O:GMED240315C00065000 OCASPS Call American 100 65 BATO 2024-03-15
O:GMED240315C00062500 OCASPS Call American 100 62.5 BATO 2024-03-15
O:GMED240315C00060000 OCASPS Call American 100 60 BATO 2024-03-15
O:GMED240315C00057500 OCASPS Call American 100 57.5 BATO 2024-03-15
O:GMED240315C00055000 OCASPS Call American 100 55 BATO 2024-03-15
O:GMED240315C00052500 OCASPS Call American 100 52.5 BATO 2024-03-15
O:GMED240315C00050000 OCASPS Call American 100 50 BATO 2024-03-15
O:GMED240315C00047500 OCASPS Call American 100 47.5 BATO 2024-03-15
O:GMED240315C00045000 OCASPS Call American 100 45 BATO 2024-03-15
O:GMED240315C00042500 OCASPS Call American 100 42.5 BATO 2024-03-15
O:GMED240315C00040000 OCASPS Call American 100 40 BATO 2024-03-15
O:GMED240315C00037500 OCASPS Call American 100 37.5 BATO 2024-03-15
O:GMED240315C00035000 OCASPS Call American 100 35 BATO 2024-03-15
O:GMED1240315P00065000 OPASPN Put American 75 65 BATO 2024-03-15
O:GMED1240315P00060000 OPASPN Put American 75 60 BATO 2024-03-15
O:GMED1240315P00055000 OPASPN Put American 75 55 BATO 2024-03-15
O:GMED1240315P00050000 OPASPN Put American 75 50 BATO 2024-03-15
O:GMED1240315P00045000 OPASPN Put American 75 45 BATO 2024-03-15
O:GMED1240315P00040000 OPASPN Put American 75 40 BATO 2024-03-15
O:GMED1240315P00035000 OPASPN Put American 75 35 BATO 2024-03-15
O:GMED1240315P00030000 OPASPN Put American 75 30 BATO 2024-03-15
O:GMED1240315P00025000 OPASPN Put American 75 25 BATO 2024-03-15
O:GMED1240315P00022500 OPASPN Put American 75 22.5 BATO 2024-03-15
O:GMED1240315C00065000 OCASPN Call American 75 65 BATO 2024-03-15
O:GMED1240315C00060000 OCASPN Call American 75 60 BATO 2024-03-15
O:GMED1240315C00055000 OCASPN Call American 75 55 BATO 2024-03-15
O:GMED240315P00032500 OPASPS Put American 100 32.5 BATO 2024-03-15
O:GMED1240315C00050000 OCASPN Call American 75 50 BATO 2024-03-15
O:GMED1240315C00045000 OCASPN Call American 75 45 BATO 2024-03-15
O:GMED1240315C00040000 OCASPN Call American 75 40 BATO 2024-03-15
O:GMED240315P00030000 OPASPS Put American 100 30 BATO 2024-03-15
O:GMED1240315C00035000 OCASPN Call American 75 35 BATO 2024-03-15
O:GMED1240315C00030000 OCASPN Call American 75 30 BATO 2024-03-15
O:GMED1240315C00025000 OCASPN Call American 75 25 BATO 2024-03-15
O:GMED240315P00027500 OPASPS Put American 100 27.5 BATO 2024-03-15
O:GMED1240315C00022500 OCASPN Call American 75 22.5 BATO 2024-03-15
O:GMED240315P00025000 OPASPS Put American 100 25 BATO 2024-03-15
O:GMED240216P00065000 OPASPS Put American 100 65 BATO 2024-02-16
O:GMED240216P00060000 OPASPS Put American 100 60 BATO 2024-02-16
O:GMED240216P00057500 OPASPS Put American 100 57.5 BATO 2024-02-16
O:GMED240216P00055000 OPASPS Put American 100 55 BATO 2024-02-16
O:GMED240216P00052500 OPASPS Put American 100 52.5 BATO 2024-02-16
O:GMED240216P00050000 OPASPS Put American 100 50 BATO 2024-02-16
O:GMED240216P00047500 OPASPS Put American 100 47.5 BATO 2024-02-16
O:GMED240216P00045000 OPASPS Put American 100 45 BATO 2024-02-16
O:GMED240216P00042500 OPASPS Put American 100 42.5 BATO 2024-02-16
O:GMED240216P00040000 OPASPS Put American 100 40 BATO 2024-02-16
O:GMED240216P00062500 OPASPS Put American 100 62.5 BATO 2024-02-16
O:GMED240216C00062500 OCASPS Call American 100 62.5 BATO 2024-02-16
O:GMED240216P00037500 OPASPS Put American 100 37.5 BATO 2024-02-16
O:GMED240216P00035000 OPASPS Put American 100 35 BATO 2024-02-16
O:GMED240216P00032500 OPASPS Put American 100 32.5 BATO 2024-02-16
O:GMED240216P00030000 OPASPS Put American 100 30 BATO 2024-02-16
O:GMED240216P00027500 OPASPS Put American 100 27.5 BATO 2024-02-16
O:GMED240216P00025000 OPASPS Put American 100 25 BATO 2024-02-16
O:GMED240216C00065000 OCASPS Call American 100 65 BATO 2024-02-16
O:GMED240216C00060000 OCASPS Call American 100 60 BATO 2024-02-16
O:GMED240216C00057500 OCASPS Call American 100 57.5 BATO 2024-02-16
O:GMED240216C00055000 OCASPS Call American 100 55 BATO 2024-02-16
O:GMED240216C00052500 OCASPS Call American 100 52.5 BATO 2024-02-16
O:GMED240216C00050000 OCASPS Call American 100 50 BATO 2024-02-16
O:GMED240216C00047500 OCASPS Call American 100 47.5 BATO 2024-02-16
O:GMED240216C00045000 OCASPS Call American 100 45 BATO 2024-02-16
O:GMED240216C00042500 OCASPS Call American 100 42.5 BATO 2024-02-16
O:GMED240216C00040000 OCASPS Call American 100 40 BATO 2024-02-16
O:GMED240216C00037500 OCASPS Call American 100 37.5 BATO 2024-02-16
O:GMED240216C00035000 OCASPS Call American 100 35 BATO 2024-02-16
O:GMED240216C00032500 OCASPS Call American 100 32.5 BATO 2024-02-16
O:GMED240216C00030000 OCASPS Call American 100 30 BATO 2024-02-16
O:GMED240216C00027500 OCASPS Call American 100 27.5 BATO 2024-02-16
O:GMED240216C00025000 OCASPS Call American 100 25 BATO 2024-02-16
O:GMED240119P00065000 OPASPS Put American 100 65 BATO 2024-01-19
O:GMED240119P00025000 OPASPS Put American 100 25 BATO 2024-01-19
O:GMED240119P00022500 OPASPS Put American 100 22.5 BATO 2024-01-19
O:GMED240119C00065000 OCASPS Call American 100 65 BATO 2024-01-19
O:GMED240119C00025000 OCASPS Call American 100 25 BATO 2024-01-19
O:GMED240119C00022500 OCASPS Call American 100 22.5 BATO 2024-01-19
O:GMED240119P00057500 OPASPS Put American 100 57.5 BATO 2024-01-19
O:GMED240119C00057500 OCASPS Call American 100 57.5 BATO 2024-01-19
O:GMED240119P00062500 OPASPS Put American 100 62.5 BATO 2024-01-19
O:GMED240119P00060000 OPASPS Put American 100 60 BATO 2024-01-19
O:GMED240119C00062500 OCASPS Call American 100 62.5 BATO 2024-01-19
O:GMED240119P00055000 OPASPS Put American 100 55 BATO 2024-01-19
O:GMED240119P00052500 OPASPS Put American 100 52.5 BATO 2024-01-19
O:GMED240119P00050000 OPASPS Put American 100 50 BATO 2024-01-19
O:GMED240119P00047500 OPASPS Put American 100 47.5 BATO 2024-01-19
O:GMED240119P00045000 OPASPS Put American 100 45 BATO 2024-01-19
O:GMED240119P00042500 OPASPS Put American 100 42.5 BATO 2024-01-19
O:GMED240119P00040000 OPASPS Put American 100 40 BATO 2024-01-19
O:GMED240119P00037500 OPASPS Put American 100 37.5 BATO 2024-01-19
O:GMED240119P00035000 OPASPS Put American 100 35 BATO 2024-01-19
O:GMED240119P00032500 OPASPS Put American 100 32.5 BATO 2024-01-19
O:GMED240119P00030000 OPASPS Put American 100 30 BATO 2024-01-19
O:GMED240119P00027500 OPASPS Put American 100 27.5 BATO 2024-01-19
O:GMED240119C00060000 OCASPS Call American 100 60 BATO 2024-01-19
O:GMED240119C00055000 OCASPS Call American 100 55 BATO 2024-01-19
O:GMED240119C00052500 OCASPS Call American 100 52.5 BATO 2024-01-19
O:GMED240119C00050000 OCASPS Call American 100 50 BATO 2024-01-19
O:GMED240119C00047500 OCASPS Call American 100 47.5 BATO 2024-01-19
O:GMED240119C00045000 OCASPS Call American 100 45 BATO 2024-01-19
O:GMED240119C00042500 OCASPS Call American 100 42.5 BATO 2024-01-19
O:GMED240119C00040000 OCASPS Call American 100 40 BATO 2024-01-19
O:GMED240119C00037500 OCASPS Call American 100 37.5 BATO 2024-01-19
O:GMED240119C00035000 OCASPS Call American 100 35 BATO 2024-01-19
O:GMED240119C00032500 OCASPS Call American 100 32.5 BATO 2024-01-19
O:GMED240119C00030000 OCASPS Call American 100 30 BATO 2024-01-19
O:GMED240119C00027500 OCASPS Call American 100 27.5 BATO 2024-01-19
O:GMED231215C00052500 OCASPS Call American 100 52.5 BATO 2023-12-15
O:GMED231215C00050000 OCASPS Call American 100 50 BATO 2023-12-15
O:GMED231215C00025000 OCASPS Call American 100 25 BATO 2023-12-15
O:GMED231215C00047500 OCASPS Call American 100 47.5 BATO 2023-12-15
O:GMED231215C00045000 OCASPS Call American 100 45 BATO 2023-12-15
O:GMED231215C00042500 OCASPS Call American 100 42.5 BATO 2023-12-15
O:GMED231215C00040000 OCASPS Call American 100 40 BATO 2023-12-15
O:GMED231215C00037500 OCASPS Call American 100 37.5 BATO 2023-12-15
O:GMED231215C00035000 OCASPS Call American 100 35 BATO 2023-12-15
O:GMED231215P00032500 OPASPS Put American 100 32.5 BATO 2023-12-15
O:GMED231215P00030000 OPASPS Put American 100 30 BATO 2023-12-15
O:GMED231215P00027500 OPASPS Put American 100 27.5 BATO 2023-12-15
O:GMED231215C00032500 OCASPS Call American 100 32.5 BATO 2023-12-15
O:GMED231215C00030000 OCASPS Call American 100 30 BATO 2023-12-15
O:GMED231215C00027500 OCASPS Call American 100 27.5 BATO 2023-12-15
O:GMED1231215P00065000 OPASPN Put American 75 65 BATO 2023-12-15
O:GMED1231215P00060000 OPASPN Put American 75 60 BATO 2023-12-15
O:GMED1231215P00055000 OPASPN Put American 75 55 BATO 2023-12-15
O:GMED1231215P00050000 OPASPN Put American 75 50 BATO 2023-12-15
O:GMED1231215P00045000 OPASPN Put American 75 45 BATO 2023-12-15
O:GMED1231215P00040000 OPASPN Put American 75 40 BATO 2023-12-15
O:GMED1231215P00035000 OPASPN Put American 75 35 BATO 2023-12-15
O:GMED1231215P00030000 OPASPN Put American 75 30 BATO 2023-12-15
O:GMED1231215P00025000 OPASPN Put American 75 25 BATO 2023-12-15
O:GMED1231215P00022500 OPASPN Put American 75 22.5 BATO 2023-12-15
O:GMED1231215C00065000 OCASPN Call American 75 65 BATO 2023-12-15
O:GMED1231215C00060000 OCASPN Call American 75 60 BATO 2023-12-15
O:GMED1231215C00055000 OCASPN Call American 75 55 BATO 2023-12-15
O:GMED1231215C00050000 OCASPN Call American 75 50 BATO 2023-12-15
O:GMED1231215C00045000 OCASPN Call American 75 45 BATO 2023-12-15
O:GMED1231215C00040000 OCASPN Call American 75 40 BATO 2023-12-15
O:GMED1231215C00035000 OCASPN Call American 75 35 BATO 2023-12-15
O:GMED1231215C00030000 OCASPN Call American 75 30 BATO 2023-12-15
O:GMED1231215C00025000 OCASPN Call American 75 25 BATO 2023-12-15
O:GMED1231215C00022500 OCASPN Call American 75 22.5 BATO 2023-12-15
O:GMED231215P00085000 OPASPS Put American 100 85 BATO 2023-12-15
O:GMED231215P00080000 OPASPS Put American 100 80 BATO 2023-12-15
O:GMED231215P00075000 OPASPS Put American 100 75 BATO 2023-12-15
O:GMED231215P00070000 OPASPS Put American 100 70 BATO 2023-12-15
O:GMED231215P00067500 OPASPS Put American 100 67.5 BATO 2023-12-15
O:GMED231215P00065000 OPASPS Put American 100 65 BATO 2023-12-15
O:GMED231215P00062500 OPASPS Put American 100 62.5 BATO 2023-12-15
O:GMED231215P00060000 OPASPS Put American 100 60 BATO 2023-12-15
O:GMED231215P00057500 OPASPS Put American 100 57.5 BATO 2023-12-15
O:GMED231215P00055000 OPASPS Put American 100 55 BATO 2023-12-15
O:GMED231215P00052500 OPASPS Put American 100 52.5 BATO 2023-12-15
O:GMED231215P00050000 OPASPS Put American 100 50 BATO 2023-12-15
O:GMED231215P00047500 OPASPS Put American 100 47.5 BATO 2023-12-15
O:GMED231215P00045000 OPASPS Put American 100 45 BATO 2023-12-15
O:GMED231215P00042500 OPASPS Put American 100 42.5 BATO 2023-12-15
O:GMED231215P00040000 OPASPS Put American 100 40 BATO 2023-12-15
O:GMED231215P00037500 OPASPS Put American 100 37.5 BATO 2023-12-15
O:GMED231215P00035000 OPASPS Put American 100 35 BATO 2023-12-15
O:GMED231215C00085000 OCASPS Call American 100 85 BATO 2023-12-15
O:GMED231215P00025000 OPASPS Put American 100 25 BATO 2023-12-15
O:GMED231215C00080000 OCASPS Call American 100 80 BATO 2023-12-15
O:GMED231215C00075000 OCASPS Call American 100 75 BATO 2023-12-15
O:GMED231215C00070000 OCASPS Call American 100 70 BATO 2023-12-15
O:GMED231215C00067500 OCASPS Call American 100 67.5 BATO 2023-12-15
O:GMED231215C00065000 OCASPS Call American 100 65 BATO 2023-12-15
O:GMED231215C00062500 OCASPS Call American 100 62.5 BATO 2023-12-15
O:GMED231215C00060000 OCASPS Call American 100 60 BATO 2023-12-15
O:GMED231215C00057500 OCASPS Call American 100 57.5 BATO 2023-12-15
O:GMED231215C00055000 OCASPS Call American 100 55 BATO 2023-12-15
O:GMED231117P00080000 OPASPS Put American 100 80 BATO 2023-11-17
O:GMED231117P00077500 OPASPS Put American 100 77.5 BATO 2023-11-17
O:GMED231117P00075000 OPASPS Put American 100 75 BATO 2023-11-17
O:GMED231117P00072500 OPASPS Put American 100 72.5 BATO 2023-11-17
O:GMED231117P00070000 OPASPS Put American 100 70 BATO 2023-11-17
O:GMED231117P00067500 OPASPS Put American 100 67.5 BATO 2023-11-17
O:GMED231117P00065000 OPASPS Put American 100 65 BATO 2023-11-17
O:GMED231117P00062500 OPASPS Put American 100 62.5 BATO 2023-11-17
O:GMED231117P00060000 OPASPS Put American 100 60 BATO 2023-11-17
O:GMED231117P00057500 OPASPS Put American 100 57.5 BATO 2023-11-17
O:GMED231117P00055000 OPASPS Put American 100 55 BATO 2023-11-17
O:GMED231117P00052500 OPASPS Put American 100 52.5 BATO 2023-11-17
O:GMED231117P00050000 OPASPS Put American 100 50 BATO 2023-11-17
O:GMED231117P00047500 OPASPS Put American 100 47.5 BATO 2023-11-17
O:GMED231117P00045000 OPASPS Put American 100 45 BATO 2023-11-17
O:GMED231117P00042500 OPASPS Put American 100 42.5 BATO 2023-11-17
O:GMED231117P00040000 OPASPS Put American 100 40 BATO 2023-11-17
O:GMED231117P00037500 OPASPS Put American 100 37.5 BATO 2023-11-17
O:GMED231117P00035000 OPASPS Put American 100 35 BATO 2023-11-17
O:GMED231117P00032500 OPASPS Put American 100 32.5 BATO 2023-11-17
O:GMED231117C00110000 OCASPS Call American 100 110 BATO 2023-11-17
O:GMED231117C00105000 OCASPS Call American 100 105 BATO 2023-11-17
O:GMED231117C00100000 OCASPS Call American 100 100 BATO 2023-11-17
O:GMED231117C00095000 OCASPS Call American 100 95 BATO 2023-11-17
O:GMED231117C00090000 OCASPS Call American 100 90 BATO 2023-11-17
O:GMED231117C00085000 OCASPS Call American 100 85 BATO 2023-11-17
O:GMED231117C00082500 OCASPS Call American 100 82.5 BATO 2023-11-17
O:GMED231117C00080000 OCASPS Call American 100 80 BATO 2023-11-17
O:GMED231117C00077500 OCASPS Call American 100 77.5 BATO 2023-11-17
O:GMED231117C00075000 OCASPS Call American 100 75 BATO 2023-11-17
O:GMED231117C00072500 OCASPS Call American 100 72.5 BATO 2023-11-17
O:GMED231117C00070000 OCASPS Call American 100 70 BATO 2023-11-17
O:GMED231117C00067500 OCASPS Call American 100 67.5 BATO 2023-11-17
O:GMED231117C00065000 OCASPS Call American 100 65 BATO 2023-11-17
O:GMED231117C00062500 OCASPS Call American 100 62.5 BATO 2023-11-17
O:GMED231117C00060000 OCASPS Call American 100 60 BATO 2023-11-17
O:GMED231117C00057500 OCASPS Call American 100 57.5 BATO 2023-11-17
O:GMED231117C00055000 OCASPS Call American 100 55 BATO 2023-11-17
O:GMED231117C00052500 OCASPS Call American 100 52.5 BATO 2023-11-17
O:GMED231117C00050000 OCASPS Call American 100 50 BATO 2023-11-17
O:GMED231117C00047500 OCASPS Call American 100 47.5 BATO 2023-11-17
O:GMED231117C00045000 OCASPS Call American 100 45 BATO 2023-11-17
O:GMED231117C00042500 OCASPS Call American 100 42.5 BATO 2023-11-17
O:GMED231117C00040000 OCASPS Call American 100 40 BATO 2023-11-17
O:GMED231117C00037500 OCASPS Call American 100 37.5 BATO 2023-11-17
O:GMED231117C00035000 OCASPS Call American 100 35 BATO 2023-11-17
O:GMED231117C00032500 OCASPS Call American 100 32.5 BATO 2023-11-17
O:GMED231117P00030000 OPASPS Put American 100 30 BATO 2023-11-17
O:GMED231117P00027500 OPASPS Put American 100 27.5 BATO 2023-11-17
O:GMED231117P00025000 OPASPS Put American 100 25 BATO 2023-11-17
O:GMED231117C00030000 OCASPS Call American 100 30 BATO 2023-11-17
O:GMED231117C00027500 OCASPS Call American 100 27.5 BATO 2023-11-17
O:GMED231117P00110000 OPASPS Put American 100 110 BATO 2023-11-17
O:GMED231117P00105000 OPASPS Put American 100 105 BATO 2023-11-17
O:GMED231117C00025000 OCASPS Call American 100 25 BATO 2023-11-17
O:GMED231117P00100000 OPASPS Put American 100 100 BATO 2023-11-17
O:GMED231117P00095000 OPASPS Put American 100 95 BATO 2023-11-17
O:GMED231117P00090000 OPASPS Put American 100 90 BATO 2023-11-17
O:GMED231117P00085000 OPASPS Put American 100 85 BATO 2023-11-17
O:GMED231117P00082500 OPASPS Put American 100 82.5 BATO 2023-11-17
O:GMED231020P00085000 OPASPS Put American 100 85 BATO 2023-10-20
O:GMED231020P00080000 OPASPS Put American 100 80 BATO 2023-10-20
O:GMED231020P00075000 OPASPS Put American 100 75 BATO 2023-10-20
O:GMED231020P00070000 OPASPS Put American 100 70 BATO 2023-10-20
O:GMED231020P00065000 OPASPS Put American 100 65 BATO 2023-10-20
O:GMED231020P00062500 OPASPS Put American 100 62.5 BATO 2023-10-20
O:GMED231020P00060000 OPASPS Put American 100 60 BATO 2023-10-20
O:GMED231020P00057500 OPASPS Put American 100 57.5 BATO 2023-10-20
O:GMED231020P00055000 OPASPS Put American 100 55 BATO 2023-10-20
O:GMED231020P00052500 OPASPS Put American 100 52.5 BATO 2023-10-20
O:GMED231020P00050000 OPASPS Put American 100 50 BATO 2023-10-20
O:GMED231020P00047500 OPASPS Put American 100 47.5 BATO 2023-10-20
O:GMED231020P00045000 OPASPS Put American 100 45 BATO 2023-10-20
O:GMED231020P00042500 OPASPS Put American 100 42.5 BATO 2023-10-20
O:GMED231020P00040000 OPASPS Put American 100 40 BATO 2023-10-20
O:GMED231020P00037500 OPASPS Put American 100 37.5 BATO 2023-10-20
O:GMED231020P00035000 OPASPS Put American 100 35 BATO 2023-10-20
O:GMED231020P00032500 OPASPS Put American 100 32.5 BATO 2023-10-20
O:GMED231020P00030000 OPASPS Put American 100 30 BATO 2023-10-20
O:GMED231020P00027500 OPASPS Put American 100 27.5 BATO 2023-10-20
O:GMED231020P00025000 OPASPS Put American 100 25 BATO 2023-10-20
O:GMED231020C00085000 OCASPS Call American 100 85 BATO 2023-10-20
O:GMED231020C00080000 OCASPS Call American 100 80 BATO 2023-10-20
O:GMED231020C00075000 OCASPS Call American 100 75 BATO 2023-10-20
O:GMED231020C00070000 OCASPS Call American 100 70 BATO 2023-10-20
O:GMED231020C00065000 OCASPS Call American 100 65 BATO 2023-10-20
O:GMED231020C00062500 OCASPS Call American 100 62.5 BATO 2023-10-20
O:GMED231020C00060000 OCASPS Call American 100 60 BATO 2023-10-20
O:GMED231020C00057500 OCASPS Call American 100 57.5 BATO 2023-10-20
O:GMED231020C00055000 OCASPS Call American 100 55 BATO 2023-10-20
O:GMED231020C00052500 OCASPS Call American 100 52.5 BATO 2023-10-20
O:GMED231020C00050000 OCASPS Call American 100 50 BATO 2023-10-20
O:GMED231020C00047500 OCASPS Call American 100 47.5 BATO 2023-10-20
O:GMED231020C00045000 OCASPS Call American 100 45 BATO 2023-10-20
O:GMED231020C00042500 OCASPS Call American 100 42.5 BATO 2023-10-20
O:GMED231020C00040000 OCASPS Call American 100 40 BATO 2023-10-20
O:GMED231020C00037500 OCASPS Call American 100 37.5 BATO 2023-10-20
O:GMED231020C00035000 OCASPS Call American 100 35 BATO 2023-10-20
O:GMED231020C00032500 OCASPS Call American 100 32.5 BATO 2023-10-20
O:GMED231020C00030000 OCASPS Call American 100 30 BATO 2023-10-20
O:GMED231020C00027500 OCASPS Call American 100 27.5 BATO 2023-10-20
O:GMED231020C00025000 OCASPS Call American 100 25 BATO 2023-10-20
O:GMED1231020P00060000 OPASPN Put American 75 60 BATO 2023-10-20
O:GMED1231020P00055000 OPASPN Put American 75 55 BATO 2023-10-20
O:GMED1231020P00050000 OPASPN Put American 75 50 BATO 2023-10-20
O:GMED1231020P00045000 OPASPN Put American 75 45 BATO 2023-10-20
O:GMED1231020P00040000 OPASPN Put American 75 40 BATO 2023-10-20
O:GMED1231020P00035000 OPASPN Put American 75 35 BATO 2023-10-20
O:GMED1231020P00030000 OPASPN Put American 75 30 BATO 2023-10-20
O:GMED1231020P00025000 OPASPN Put American 75 25 BATO 2023-10-20
O:GMED1231020P00022500 OPASPN Put American 75 22.5 BATO 2023-10-20
O:GMED1231020P00020000 OPASPN Put American 75 20 BATO 2023-10-20
O:GMED1231020C00060000 OCASPN Call American 75 60 BATO 2023-10-20
O:GMED1231020C00055000 OCASPN Call American 75 55 BATO 2023-10-20
O:GMED1231020C00050000 OCASPN Call American 75 50 BATO 2023-10-20
O:GMED1231020C00045000 OCASPN Call American 75 45 BATO 2023-10-20
O:GMED1231020C00040000 OCASPN Call American 75 40 BATO 2023-10-20
O:GMED1231020C00035000 OCASPN Call American 75 35 BATO 2023-10-20
O:GMED1231020C00030000 OCASPN Call American 75 30 BATO 2023-10-20
O:GMED1231020C00025000 OCASPN Call American 75 25 BATO 2023-10-20
O:GMED1231020C00022500 OCASPN Call American 75 22.5 BATO 2023-10-20
O:GMED1231020C00020000 OCASPN Call American 75 20 BATO 2023-10-20
O:GMED230915P00110000 OPASPS Put American 100 110 BATO 2023-09-15
O:GMED230915P00105000 OPASPS Put American 100 105 BATO 2023-09-15
O:GMED230915P00100000 OPASPS Put American 100 100 BATO 2023-09-15
O:GMED230915P00095000 OPASPS Put American 100 95 BATO 2023-09-15
O:GMED230915P00090000 OPASPS Put American 100 90 BATO 2023-09-15
O:GMED230915P00087500 OPASPS Put American 100 87.5 BATO 2023-09-15
O:GMED230915P00085000 OPASPS Put American 100 85 BATO 2023-09-15
O:GMED230915P00082500 OPASPS Put American 100 82.5 BATO 2023-09-15
O:GMED230915P00080000 OPASPS Put American 100 80 BATO 2023-09-15
O:GMED230915P00077500 OPASPS Put American 100 77.5 BATO 2023-09-15
O:GMED230915P00075000 OPASPS Put American 100 75 BATO 2023-09-15
O:GMED230915P00072500 OPASPS Put American 100 72.5 BATO 2023-09-15
O:GMED230915P00070000 OPASPS Put American 100 70 BATO 2023-09-15
O:GMED230915P00067500 OPASPS Put American 100 67.5 BATO 2023-09-15
O:GMED230915P00065000 OPASPS Put American 100 65 BATO 2023-09-15
O:GMED230915P00062500 OPASPS Put American 100 62.5 BATO 2023-09-15
O:GMED230915P00060000 OPASPS Put American 100 60 BATO 2023-09-15
O:GMED230915P00057500 OPASPS Put American 100 57.5 BATO 2023-09-15
O:GMED230915P00055000 OPASPS Put American 100 55 BATO 2023-09-15
O:GMED230915P00052500 OPASPS Put American 100 52.5 BATO 2023-09-15
O:GMED230915P00050000 OPASPS Put American 100 50 BATO 2023-09-15
O:GMED230915P00047500 OPASPS Put American 100 47.5 BATO 2023-09-15
O:GMED230915P00045000 OPASPS Put American 100 45 BATO 2023-09-15
O:GMED230915P00042500 OPASPS Put American 100 42.5 BATO 2023-09-15
O:GMED230915P00040000 OPASPS Put American 100 40 BATO 2023-09-15
O:GMED230915P00037500 OPASPS Put American 100 37.5 BATO 2023-09-15
O:GMED230915P00035000 OPASPS Put American 100 35 BATO 2023-09-15
O:GMED230915P00032500 OPASPS Put American 100 32.5 BATO 2023-09-15
O:GMED230915C00110000 OCASPS Call American 100 110 BATO 2023-09-15
O:GMED230915C00105000 OCASPS Call American 100 105 BATO 2023-09-15
O:GMED230915C00100000 OCASPS Call American 100 100 BATO 2023-09-15
O:GMED230915C00095000 OCASPS Call American 100 95 BATO 2023-09-15
O:GMED230915C00090000 OCASPS Call American 100 90 BATO 2023-09-15
O:GMED230915C00087500 OCASPS Call American 100 87.5 BATO 2023-09-15
O:GMED230915C00085000 OCASPS Call American 100 85 BATO 2023-09-15
O:GMED230915C00082500 OCASPS Call American 100 82.5 BATO 2023-09-15
O:GMED230915C00080000 OCASPS Call American 100 80 BATO 2023-09-15
O:GMED230915C00077500 OCASPS Call American 100 77.5 BATO 2023-09-15
O:GMED230915C00075000 OCASPS Call American 100 75 BATO 2023-09-15
O:GMED230915C00072500 OCASPS Call American 100 72.5 BATO 2023-09-15
O:GMED230915C00070000 OCASPS Call American 100 70 BATO 2023-09-15
O:GMED230915C00067500 OCASPS Call American 100 67.5 BATO 2023-09-15
O:GMED230915C00065000 OCASPS Call American 100 65 BATO 2023-09-15
O:GMED230915C00062500 OCASPS Call American 100 62.5 BATO 2023-09-15
O:GMED230915C00060000 OCASPS Call American 100 60 BATO 2023-09-15
O:GMED230915C00057500 OCASPS Call American 100 57.5 BATO 2023-09-15
O:GMED230915C00055000 OCASPS Call American 100 55 BATO 2023-09-15
O:GMED230915C00052500 OCASPS Call American 100 52.5 BATO 2023-09-15
O:GMED230915C00050000 OCASPS Call American 100 50 BATO 2023-09-15
O:GMED230915C00047500 OCASPS Call American 100 47.5 BATO 2023-09-15
O:GMED230915C00045000 OCASPS Call American 100 45 BATO 2023-09-15
O:GMED230915C00042500 OCASPS Call American 100 42.5 BATO 2023-09-15
O:GMED230915C00040000 OCASPS Call American 100 40 BATO 2023-09-15
O:GMED230915C00037500 OCASPS Call American 100 37.5 BATO 2023-09-15
O:GMED230915C00035000 OCASPS Call American 100 35 BATO 2023-09-15
O:GMED230915C00032500 OCASPS Call American 100 32.5 BATO 2023-09-15
O:GMED1230915P00070000 OPASPN Put American 75 70 BATO 2023-09-15
O:GMED1230915P00065000 OPASPN Put American 75 65 BATO 2023-09-15
O:GMED1230915P00060000 OPASPN Put American 75 60 BATO 2023-09-15
O:GMED1230915P00055000 OPASPN Put American 75 55 BATO 2023-09-15
O:GMED1230915P00050000 OPASPN Put American 75 50 BATO 2023-09-15
O:GMED1230915P00045000 OPASPN Put American 75 45 BATO 2023-09-15
O:GMED1230915P00040000 OPASPN Put American 75 40 BATO 2023-09-15
O:GMED1230915P00035000 OPASPN Put American 75 35 BATO 2023-09-15
O:GMED1230915P00030000 OPASPN Put American 75 30 BATO 2023-09-15
O:GMED1230915P00025000 OPASPN Put American 75 25 BATO 2023-09-15
O:GMED1230915P00022500 OPASPN Put American 75 22.5 BATO 2023-09-15
O:GMED1230915C00070000 OCASPN Call American 75 70 BATO 2023-09-15
O:GMED1230915C00065000 OCASPN Call American 75 65 BATO 2023-09-15
O:GMED1230915C00060000 OCASPN Call American 75 60 BATO 2023-09-15
O:GMED1230915C00055000 OCASPN Call American 75 55 BATO 2023-09-15
O:GMED1230915C00050000 OCASPN Call American 75 50 BATO 2023-09-15
O:GMED1230915C00045000 OCASPN Call American 75 45 BATO 2023-09-15
O:GMED1230915C00040000 OCASPN Call American 75 40 BATO 2023-09-15
O:GMED1230915C00035000 OCASPN Call American 75 35 BATO 2023-09-15
O:GMED1230915C00030000 OCASPN Call American 75 30 BATO 2023-09-15
O:GMED1230915C00025000 OCASPN Call American 75 25 BATO 2023-09-15
O:GMED1230915C00022500 OCASPN Call American 75 22.5 BATO 2023-09-15
O:GMED230818P00085000 OPASPS Put American 100 85 BATO 2023-08-18
O:GMED230818P00080000 OPASPS Put American 100 80 BATO 2023-08-18
O:GMED230818P00075000 OPASPS Put American 100 75 BATO 2023-08-18
O:GMED230818P00070000 OPASPS Put American 100 70 BATO 2023-08-18
O:GMED230818P00065000 OPASPS Put American 100 65 BATO 2023-08-18
O:GMED230818P00062500 OPASPS Put American 100 62.5 BATO 2023-08-18
O:GMED230818P00060000 OPASPS Put American 100 60 BATO 2023-08-18
O:GMED230818P00057500 OPASPS Put American 100 57.5 BATO 2023-08-18
O:GMED230818P00055000 OPASPS Put American 100 55 BATO 2023-08-18
O:GMED230818P00052500 OPASPS Put American 100 52.5 BATO 2023-08-18
O:GMED230818P00050000 OPASPS Put American 100 50 BATO 2023-08-18
O:GMED230818P00047500 OPASPS Put American 100 47.5 BATO 2023-08-18
O:GMED230818P00045000 OPASPS Put American 100 45 BATO 2023-08-18
O:GMED230818P00042500 OPASPS Put American 100 42.5 BATO 2023-08-18
O:GMED230818P00040000 OPASPS Put American 100 40 BATO 2023-08-18
O:GMED230818P00037500 OPASPS Put American 100 37.5 BATO 2023-08-18
O:GMED230818P00035000 OPASPS Put American 100 35 BATO 2023-08-18
O:GMED230818C00085000 OCASPS Call American 100 85 BATO 2023-08-18
O:GMED230818C00080000 OCASPS Call American 100 80 BATO 2023-08-18
O:GMED230818C00075000 OCASPS Call American 100 75 BATO 2023-08-18
O:GMED230818C00070000 OCASPS Call American 100 70 BATO 2023-08-18
O:GMED230818C00065000 OCASPS Call American 100 65 BATO 2023-08-18
O:GMED230818C00062500 OCASPS Call American 100 62.5 BATO 2023-08-18
O:GMED230818C00060000 OCASPS Call American 100 60 BATO 2023-08-18
O:GMED230818C00057500 OCASPS Call American 100 57.5 BATO 2023-08-18
O:GMED230818C00055000 OCASPS Call American 100 55 BATO 2023-08-18
O:GMED230818C00052500 OCASPS Call American 100 52.5 BATO 2023-08-18
O:GMED230818C00050000 OCASPS Call American 100 50 BATO 2023-08-18
O:GMED230818C00047500 OCASPS Call American 100 47.5 BATO 2023-08-18
O:GMED230818C00045000 OCASPS Call American 100 45 BATO 2023-08-18
O:GMED230818C00042500 OCASPS Call American 100 42.5 BATO 2023-08-18
O:GMED230818C00040000 OCASPS Call American 100 40 BATO 2023-08-18
O:GMED230818C00037500 OCASPS Call American 100 37.5 BATO 2023-08-18
O:GMED230818C00035000 OCASPS Call American 100 35 BATO 2023-08-18
News Stream
News earningscall-transcripts
Globus Medical (GMED) Q1 2024 Earnings Call Transcript
GMED earnings call for the period ending March 31, 2024.
The Motley Fool • 1w ago
Stocks Earnings Releases and Operating Results
Globus Medical Reports First Quarter 2024 Results
AUDUBON, Pa., May 07, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the quarter ended March 31, 2024.
GlobeNewswire Inc. • 1w ago
News Conference Calls/ Webcasts
Globus Medical Schedules First Quarter Earnings Release and Conference Call
AUDUBON, Pa., April 16, 2024 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal solutions company, will announce its financial results for the first quarter ended March 31, 2024 after the market close on Tuesday, May 7, 2024. A copy of the release will be available on the Globus Medical website at www.investors.globusmedical.com.
GlobeNewswire Inc. • 1mo ago
News News
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • 1mo ago
News News
Globus Medical (GMED) Down 5.8% Since Last Earnings Report: Can It Rebound?
Globus Medical (GMED) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks Investment Research • 1mo ago
Analyst Analyst Ratings
The Latest Analyst Ratings For Globus Medical
6 analysts have expressed a variety of opinions on Globus Medical (NYSE:GMED) over the past quarter, offering a diverse set of opinions from bullish to bearish. The table below provides a snapshot of their recent ratings, showcasing how sentiments have evolved over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 3 1 2 0 0 Last 30D 1 0 0 0 0 1M Ago 1 0 1 0 0 2M Ago 0 0 0 0 0 3M Ago 1 1 1 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $63.83, a high estimate of $71.00, and a low estimate of $58.00. This current average reflects an increase of 6.83% from the previous average price target of $59.75. Breaking Down Analyst Ratings: A Detailed Examination An in-depth analysis of recent analyst actions unveils how financial experts perceive Globus Medical. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Ryan Zimmerman BTIG Announces Buy $60.00 - Mathew Blackman Stifel Raises Buy $64.00 $61.00 Richard Newitter Truist Securities Raises Hold $60.00 $58.00 Shagun Singh RBC Capital Maintains Outperform $70.00 - Richard Newitter Truist Securities Raises Hold $58.00 $53.00 Kyle Rose Canaccord Genuity Raises Buy $71.00 $67.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to Globus Medical. ...Full story available on Benzinga.com
Benzinga • 2mo ago
News News
Why This 1 Value Stock Could Be a Great Addition to Your Portfolio
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks Investment Research • 2mo ago
News News
Here's Why Globus Medical (GMED) is a Strong Value Stock
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Zacks Investment Research • 2mo ago
News News
Here's Why Globus Medical (GMED) is a Strong Momentum Stock
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Zacks Investment Research • 2mo ago
Analyst Analyst Ratings
Key Takeaways From Globus Medical Analyst Ratings
Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Globus Medical (NYSE:GMED) in the last three months. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 1 2 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 1 0 0 0 3M Ago 1 0 1 0 0 Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $64.75, a high estimate of $71.00, and a low estimate of $58.00. Surpassing the previous average price target of $59.33, the current average has increased by 9.14%. Decoding Analyst Ratings: A Detailed Look A clear picture of Globus Medical's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Richard Newitter Truist Securities Raises Hold $60.00 $58.00 Shagun Singh RBC Capital Maintains Outperform $70.00 - Richard Newitter Truist Securities Raises Hold $58.00 $53.00 Kyle Rose Canaccord Genuity Raises Buy $71.00 $67.00 Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Globus Medical. This insight gives a ...Full story available on Benzinga.com
Benzinga • 2mo ago
See All
Related
Latest

Contactez-nous dès aujourd'hui pour découvrir comment notre solution peut vous aider à tirer parti de la puissance des données.

CONTACTER UN EXPERT